Two free CES overview webinars on 7th & 8th January

Courtesy of Futuresource Consulting:

Wearable Technology at International CES, 15.15 GMT on 7/1/15 – to register click here

  • The killer apps on show from smartwatches, head-mounted displays and other emerging categories.
  • Will health and fitness tracking remain the primary application in the short run?
  • What are the emerging new wearables categories?
  • Are smart garments becoming a competitive reality?
  • The latest headphones trends including health tracking, sports and wireless.
  • What competitive trends are on display – prestige brands from the worlds of jewellery and fashion?
  • Beyond GoPro – the roadmap for wearable cameras and imaging beyond sports and evidential.

(more…)

2015: a few predictions (UK-biased)

As intimated in our review of last year’s predictions, we feel little need to change course significantly, however some are now done & dusted, whereas others have a way to go. The latter include a concern about doctors, especially those in hospitals, continuing to use high-risk uncertified apps where the chance of injury or death of a patient is high if there is an error in them. Uncertified dosage calculators are considered particularly concerning.

Of necessity this is an area where clinicians are unwilling to be quoted, and meetings impose Chatham House rules. Suffice to say therefore that the point has now been well taken, and the MHRA are well aware of general concerns. Our first prediction therefore is that:

One or more Royal College/College will advise or instruct its members only to use CE-certified or otherwise risk-assessed medical apps.

The challenge here of course is that a restriction to CE-certified apps-only would be a disaster as many, if not most, apps used by clinicians do not meet the definition of a Medical Device and so could not justifiably be CE-certified. And apps are now a major source of efficiencies in hospitals – (more…)

2014: a few quotes

As a coda to yesterday’s review of our predictions for 2014, here are a few quotes that particularly struck this editor as of interest in 2014, sometimes because of what was said and sometimes because of who was saying it – it’s left to the reader to decide which.

Arthur L. Caplan, Director of Medical Ethics at the New York University Langone Medical Center at the end of an interesting piece in the New York Times on the finer points of genetic testing said:

If you want to spend wisely to protect your health and you have a few hundred dollars to spare, buy a scale, stand on it, and act accordingly.

Three months later, Anne Wojcicki, the founder of 23andme – one of the genetic testing organisations mentioned in the last clip – was quoted in this Medcity News piece as saying: (more…)

Looking back over Telehealth & Telecare Aware’s predictions for 2014

Looking back over our predictions made on 31st December last year, it’s hard to quibble with any, and worth hanging on to those that didn’t come good this year.

Our first was

Security and data privacy issues will become a serious mHealth issue in 2014; developers failing to take great care over security and privacy issues will risk very adverse publicity and worse.

Job done: that certainly proved correct, with many being exposed as either selling or potentially selling private information. Clinicians were not immune from privacy invasion eitherHere is a US summary of the issues. Attention was drawn to an EU Article 29 data protection opinion (actually published in 2013) that sought to clarify the legal framework applicable to the processing of personal data in the development, distribution and usage of apps on smart devices, and the obligations to take adequate security measures.   Many apps got hacked too, including FDA-approved ones. There were also items, such as this one, demonstrating how complex the law is in this area in the US. In the EU, the arrival of the Data Protection Regulation in 2015 (now some say 2016) will undoubtedly improve data privacy significantly, though the failure to treat data used for health purposes differently from (more…)

Choose and book – so near yet so far (UK)

Those readers for whom a hospital appointment is very much a rarity may find the recent experiences of this editor of interest. For the only previous hospital appointment experienced by me after Choose & Book (“C&B”) had begun in our area (North East London), a few years back, my GP assured me it was broken and said someone would call to fix an appointment irrespective of any ambitions I had to book online for the first time!

For this occasion – an appointment at Charing Cross Hospital in Hammersmith – the appointment date offered did not work. However the electronic access details to change to a later date came quickly; getting online was a doddle. As it happens, as this was the peak of the pre-Christmas conference season, none of the appointments offered over a six day spread worked for me. Frustratingly, there was no option to put me on hold awaiting a later release of appointments, or to look further ahead than a few days so it was time to call the C&B helpline.

Unbelievably (more…)

Tunstall’s challenging year: results reported

[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2014/07/Big-T-thumb-480×294-55535.gif” thumb_width=”150″ /]Breaking News. The topline of Tunstall Healthcare Group’s 2014 results (through 30 Sept 14) is now (partly) public thanks to the Yorkshire Post, Tunstall’s ‘hometown paper’. (We do note that it was published on 23 Dec, in the ‘dead of night’ rolling up to the Christmas holiday.) Notably, there is no report on the Tunstall website and it is too early to show on standard corporate reporting sites such as DueDil and CompanyCheck. The YP article appears to be written partly in press release-speak, which we do not fault them for on limited news available. In summary:

  • In the 2014 FY ended 30 September, revenues were £215 million. FY2013 was £221 million, a decrease of £6 million (2.7 percent).
  • A corresponding but greater EBITDA (earnings before interest taxation depreciation and amortization) drop to £43.0 million. FY 2013 was £52.7 million, a decrease of £9.7 million (18.4 percent).
  • The good news: revenues up 6.8 percent in the Nordics, Southern Europe, Central Europe, and Australasia; Spain’s Televida as a market leader also a bright spot [TTA 19 Dec].
  • No such good news in UK and the US  (more…)

Urgent NICE consultation: a great opportunity (UK)

This is a plea for any reader interested in the future success of medical apps in the UK to take a few minutes over Christmas to respond to a consultation request from the National Institute for Health & Care Excellence (NICE), which this editor has just been made aware of. The triennial consultation on the role of NICE opened in early December and closes on 2nd January – a very short time-frame as it covers the Christmas period!

Details are here. There is a form to download so it is not a challenging task to respond.

Many readers will be aware of this editor’s campaign following extensive research, to widen the remit of NICE to include reviewing the efficacy of medical apps. This is so that doctors can confidently recommend and indeed prescribe (NICE approved) medical apps without fear of liability, in the same way that they currently do for drugs. In addition, when discussing treatments with patients, doctors can then compare the efficacy of apps and of drugs for those conditions – such as depression, anxiety and pain relief – where apps can likely do the job better, at lower cost, with no side-effects. At a stroke this would reduce the cost of drugs to the NHS and take the UK to the forefront of the mobile health revolution.

If you can spare the time over Christmas you would give one person a very Happy Christmas; many thanks in anticipation.

Qualcomm (Second) Life: a conversation with Jim Mault

One of the surprises for this Editor, and for others attending the mHealth Summit, was to see the sizable presence of Qualcomm Life on both the exposition floor and during the sessions. From a near-nil presence at ATA 2014 and gone dark on news, the floodlights snapped on last week with new partners and a new emphasis: coordination of chronic and transitional (hospital to home) care management (CCM/TCM).

On the show floor, the spotlight was on the partner companies which mixed the established with (mostly) the early and mid-stage. Readers will recognize names such as AliveCor, Telcare, OMRON, Nonin and Airstrip; not so well known are Vaica, Orion Health, Monitored Therapeutics, IMPak Health, Vital Connect, Care Connectors, toSense (CoVa), Dexcom, InteliChart, TruClinic, ForaCare, VOXX, vitaphone (outside of Europe), Propeller Health and Noom Health (a NYeC Digital Health Accelerator 2014 graduate). The partners occupy different parts of the management continuum, integrating communications, record sharing, population health management, sensor-based monitoring, traditional and non-traditional vital signs monitoring, medication management, behavioral change methodologies and PHRs. The 2net Hub is still present for data transmission, sharing and storage, but more prominent is Qualcomm Life’s HealthyCircles platform which provides the clinical management ‘glue’: secure communications, record sharing and care team coordination. HealthyCircles was purchased in mid-2013. Founder James Mault, MD, FACS joined Qualcomm Life as VP/Chief Medical Officer.

We had some post-mHealth Summit reflection time by telephone this Wednesday while Dr Mault was in Boston. (more…)

Early 2015 healthcare events & awards (UK)

The call for abstracts for Sensors in Medicine 2015 closes on 31st December. The event will be held at the Royal Geographic Society, Exhibition Road, South Kensington, London SW7 2AR on 24 – 26 March 2015. More details here.

There is an event entitled Are Telehealth and Telecare the Answer for Older People with Assisted Living Needs? on Tuesday January 13th 2015, 1 to 2.15pm. The venue is Room C143, Tait Building (Accessible through main University Building, Northampton Square, EC1V 0HB). The speaker is Joe Wherton, Senior Research Fellow, Barts and The London School of Medicine and Dentistry, Queen Mary University of London. To book a place please email Doria Pilling: d.s.pilling@city.ac.uk

Entries for the IET’s Healthcare Technologies Student & Early Career Awards close on 16th January. The event takes place on 25th February. More details here.

The Digital Health & Care Alliance (DHACA) (of which this editor is Managing Director) is holding its third Members’ Day in London on 29th January. Members can attend for free. The day will be focused on developing the responses of the nine Special Interest Groups to  the recent NHS paper on Personalised Health & Care to 2020 and on how best to avoid duplicating innovations in the health & care sector (otherwise know as ‘reinventing wheels’). More details and how to book on the new DHACA website (existing members may need to refresh their passwords).

Finally the Royal Society of Medicine’s annual Recent Development in Digital Health 2015 event takes place on February 26th. For the past two years this event, showcasing upcoming healthcare technologies, has been a sellout so early booking here is recommended!

Biomedical Catalyst – Early stage awards (UK)

Round 8 of the above was recently announced. The closing date is 28th January 2015.

In spite of what the name might suggest, these grants are available to fund innovative small and medium sized businesses (SMEs) and researchers looking to work either individually or in collaboration to develop solutions to any healthcare challenges.

More details including how to apply are here.

Hat tip to Prof Mike Short.

Saneth Wijayaratna

We have to report the sad news that Saneth Wijayaratna died recently after a very short illness

Many readers will have encountered Saneth particularly in his roles leading TeleMedCare’s UK sales, as CEO of United Health in the UK and latterly as CEO, then Chief Scientific Officer, of InHealthcare. No-one can have failed to be struck by his dedication to improving the health & care of patients at home, or of his excellent understanding of the way his products worked. He will be greatly missed.

We are still awaiting news of his funeral arrangements which we will post here as soon as received.

A boffo week for telemedicine. Will 2015 be online visits’ Big Year?

(Boffo: extremely good or successful, sensational–Webster)

Adding to Monday’s news of ATA’s telemedicine accreditation program was American Well‘s near-simultaneous announcement of an $81 million Series C funding.  This brings total funding for the eight year-old Boston-based company to over $128 million, though it is not yet profitable. According to Modern Healthcare, “The capital injection will be used to serve a number of big projects the firm has underway, company co-CEO Dr. Ido Schoenberg said in an interview. Among those are campaigning to ease regulatory constraints, scaling its provider networks and customer outreach, working with insurers to secure more favorable reimbursement and working on its technology, he said.” The institutional, private equity, and corporate investors alluded to in the company release were not disclosed. Its mobile app, Amwell, claims over 1 million downloads with a year-to-year 1,000 percent increase. Major partners include payers Anthem Health, EmblemHealth, the Blue Cross Blue Shields of Massachusetts and Louisiana, Optum Health as well as corporate clients. American Well press release, BostonInno, SEC filing. (Note to American Well: you’re telemedicine, not telehealth)

If this round of funding represents a substantial bet on American Well’s future, another is the new relationship between Walgreens‘ and rival MDLIVE. (more…)

ATA in the accreditation arena for online patient visits

[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2014/12/ata-seal-of-accreditation.png” thumb_width=”150″ /]The American Telemedicine Association (ATA) has joined the gold rush of accreditation, in this case for online ‘virtual’ visits between doctor and patient only. US providers (only) can apply to ATA’s Accreditation Program for Online Patient Consultations through a multi-step process for vetting up to three years.

  • First round application clears a company for eligibility. Through 28 Feb 2015, it is also open to ATA members only: Institutional Members, Sustaining President’s Circle and President’s Circle. On 1 March it will open to all companies in the US. Canada accreditation will start at a date to be announced in 2015.
  • Once eligible, the second round application contains ATA Administrative Rules & Terms, Standards and Guidance, Application Form, Program Overview and Fee Schedule. Fees are annual, based on the numbers of providers of online, real-time patient consults in all service lines, which presumably means areas such as primary care, behavioral, pediatric etc.
  • The company provides an application and supporting documentation. ATA then conducts a survey to review the documentation, online resources and demonstration of online services. During the process, ATA says it will notify about areas which are not compliant and organizations will have the opportunity to “provide a plan of corrective action and present corrective materials to show compliance before a final decision regarding accreditation is rendered.”
  • The accreditation is valid for three years, contingent on submitting an Annual Accreditation Report at the beginning of year 2 and 3 of its accreditation cycle.

Of interest to your Editors and readers is how this accreditation was developed.  (more…)

VA calls IBM Watson for decision making, PTSD assistance (US)

The US Department of Veterans Affairs (VA) Veterans Health Administration (VHA) area is working with IBM Watson to develop and pilot a Clinical Reasoning System to assist and accelerate decision making by primary care physicians. The $6.8 million, two-year project will concentrate on acquiring and analyzing the data generated by hundreds of thousands of VHA documents, medical records, EMRs and research papers. The second focus of the VA-Watson relationship will also include mental health–supporting veterans with PTSD who constitute 12-20 percent of US veterans from Vietnam to present. The pilot phase, interestingly, will use simulated, not real, patients.

(more…)